COVID Risk | Literature database and meta-analysis page 28

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 (severe/critical)	Complications	Thrombocytopenia [Present vs. Not present]	Odds ratio: 5.130 (1.810-14.580)	Lippi
COVID-19 (severe/critical)	Findings	Radiological finding during hospitalization [Lesion present vs. Not present]	Odds ratio: 4.460 (0.620-31.900)	Chen
COVID-19 (severe/critical)	Laboratory Findings	CD4 [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 0.550 (0.330-0.920) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	eGFR [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 0.990 (0.890-1.020) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	Lactate [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.230 (0.880-1.700)	Chen
COVID-19 (severe/critical)	Laboratory Findings	LDH [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.010 (1.000-1.020) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	AST [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 0.990 (0.960-1.030) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	ALT [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.010 (1.000-1.030)	Chen
COVID-19 (severe/critical)	Laboratory Findings	Albumin [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 0.950 (0.780-1.160) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	ESR [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.000 (0.990-1.020)	Chen
COVID-19 (severe/critical)	Laboratory Findings	CRP [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.010 (0.990-1.030) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	Lymphocytes [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 4.050 (0.890-18.500) ^§	Chen
COVID-19 (severe/critical)	Laboratory Findings	WBC [1 unit increase (at admission) vs. Not applicable]	Odds ratio: 1.070 (0.790-1.450) ^§	Chen
COVID-19 (severe/critical)	Symptoms	Body temperature [Fever present vs. Not present]	Odds ratio: 1.520 (0.340-6.850)	Chen
COVID-19 (severe/critical)	Comorbidities	Any comorbidity [Present vs. Not present]	Odds ratio: 1.830 (0.500-6.750) ^§	Chen
COVID-19 (severe/critical)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 3.380 (0.770-14.900) ^§	Chen
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.060 (1.000-1.120) ^§	Chen
COVID-19 (death)	Laboratory Findings	N-terminal pro-B-type natriuretic peptide [Abnormal at admission vs. Normal]	Hazard ratio: 1.520 (0.740-3.100) ^§	Shi
COVID-19 (death)	Laboratory Findings	N-terminal pro-B-type natriuretic peptide [Abnormal at syptom onset vs. Normal]	Hazard ratio: 1.160 (0.540-2.470) ^§	Shi
COVID-19 (death)	Laboratory Findings	Creatinine [Abnormal at admission vs. Normal]	Hazard ratio: 1.220 (0.600-2.500) ^§	Shi
COVID-19 (death)	Laboratory Findings	Creatinine [Abnormal at syptom onset vs. Normal]	Hazard ratio: 0.590 (0.290-1.230) ^§	Shi
COVID-19 (death)	Complications	Cardiac injury [Present vs. Not present]	Hazard ratio: 3.410 (1.620-7.160) ^§^†	Shi
COVID-19 (death)	Complications	Cardiac injury [Present vs. Not present]	Hazard ratio: 4.260 (1.920-9.490) ^§	Shi
COVID-19 (death)	Complications	Acute respiratory distress syndrome [Present at admission vs. Not present]	Hazard ratio: 7.110 (3.310-15.250) ^§^†	Shi
COVID-19 (death)	Complications	Acute respiratory distress syndrome [Present vs. Not present]	Hazard ratio: 7.890 (3.730-16.660) ^§	Shi
COVID-19 (death)	Comorbidities	Cancer [Present vs. Not present]	Hazard ratio: 0.820 (0.180-3.650) ^§	Shi
COVID-19 (death)	Comorbidities	Cancer [Present vs. Not present]	Hazard ratio: 1.750 (0.430-7.160) ^§	Shi
COVID-19 (death)	Comorbidities	Renal failure [Present vs. Not present]	Hazard ratio: 0.660 (0.290-1.460) ^§	Shi
COVID-19 (death)	Comorbidities	Renal failure [Present vs. Not present]	Hazard ratio: 1.100 (0.490-2.440) ^§	Shi
COVID-19 (death)	Comorbidities	COPD [Present vs. Not present]	Hazard ratio: 0.390 (0.040-3.680) ^§	Shi
COVID-19 (death)	Comorbidities	COPD [Present vs. Not present]	Hazard ratio: 0.370 (0.040-3.500) ^§	Shi
COVID-19 (death)	Comorbidities	Diabetes [Present vs. Not present]	Hazard ratio: 0.750 (0.380-1.500) ^§	Shi
COVID-19 (death)	Comorbidities	Diabetes [Present vs. Not present]	Hazard ratio: 0.790 (0.410-1.520) ^§	Shi
COVID-19 (death)	Comorbidities	Cerebrovascular disease [Present vs. Not present]	Hazard ratio: 1.710 (0.710-4.090) ^§	Shi
COVID-19 (death)	Comorbidities	Cerebrovascular disease [Present vs. Not present]	Hazard ratio: 1.120 (0.460-2.700) ^§	Shi
COVID-19 (death)	Comorbidities	Cardiovascular disease [Present vs. Not present]	Hazard ratio: 1.400 (0.650-3.030) ^§	Shi
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.020 (0.990-1.040) ^§	Shi
COVID-19 (death)	Comorbidities	Cardiovascular disease [Present vs. Not present]	Hazard ratio: 1.510 (0.700-3.300) ^§	Shi
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.020 (0.990-1.050) ^§	Shi
COVID-19 (death)	Treatment	Treatment for COVID-19 [Treated with heparin (patients with D-dimer >8 ULN) vs. Not received]	Odds ratio: 0.410 (0.210-0.820)	Tang
COVID-19 (death)	Treatment	Treatment for COVID-19 [Treated with heparin (patients with D-dimer >6 ULN) vs. Not received]	Odds ratio: 0.440 (0.230-0.870)	Tang
COVID-19 (death)	Treatment	Treatment for COVID-19 [Treated with heparin (patients with SIC score >=4) vs. Not received]	Odds ratio: 0.370 (0.150-0.900)	Tang
COVID-19 (death)	Treatment	Treatment for COVID-19 [Treated with heparin vs. Not received]	Odds ratio: 1.650 (0.930-2.920) ^§^†	Tang
COVID-19 (death)	Comorbidities	Any comorbidity [Present vs. Not present]	Odds ratio: 0.860 (0.540-1.380) ^§^†	Tang
COVID-19 (death)	Patient characteristics	Gender [Female vs. Male]	Odds ratio: 0.680 (0.430-1.080) ^§^†	Tang
COVID-19 (death)	Laboratory Findings	D-dimer [1 unit increase vs. Not applicable]	Odds ratio: 1.060 (1.030-1.090) ^§	Tang
COVID-19 (death)	Laboratory Findings	Platelet count [1 unit increase vs. Not applicable]	Odds ratio: 1.000 (0.990-1.000) ^§	Tang
COVID-19 (death)	Laboratory Findings	PT [1 unit increase vs. Not applicable]	Odds ratio: 1.110 (1.010-1.220) ^§	Tang
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.030 (1.010-1.060) ^§	Tang
COVID-19 (severe/fatal)	Findings	Radiological finding on admission [Patchy consolidation on CT on admission vs. Not present]	Hazard ratio: 5.440 (1.500-19.750) ^§^†	Zhang

If a relevant publication escaped our attention, please contact us.